Galen finds itself worth twice Elan

GALEN HOLDINGS, once the minnow in the Irish pharmaceutical sector to Elan, is now twice as valuable as the embattled Athlone-based drugs company.

Elan was once worth ten times more, but Galen is now worth twice more than Elan.

Both companies have seen their share price plummet. Elan’s market capitalisation has fallen over 96% from a 24.5bn high in June of last year to a mere 578m.